63539-0284 Ibrance - CanMED: NDC

Product NDC:

63539-0284

Brand Name:

Ibrance

Generic Name:

palbociclib

Dosage Form Name:

TABLET, FILM COATED

Administration Route:

Oral

Substances:

Name: PALBOCICLIB

Strength: 75.0

Unit: mg/1

Packages:

Code: 63539-0284-03

Description: 3 DOSE PACK in 1 CARTON (63539-284-03) / 7 TABLET, FILM COATED in 1 DOSE PACK (63539-284-07)

Effective Date: March 30, 2020

Discontinued:

SEER*Rx Category:

Chemotherapy

Major Class:

Cyclin Dependent Kinase Inhibitor

Minor Class:

CDK 4/6

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox